PMID- 37811051
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231030
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Electronic)
IS  - 2049-0801 (Linking)
VI  - 85
IP  - 10
DP  - 2023 Oct
TI  - The effect of biofeedback pelvic floor training with ACTICORE1 on urinary 
      incontinence: a multicenter randomized clinical pilot trial.
PG  - 4860-4865
LID - 10.1097/MS9.0000000000001181 [doi]
AB  - BACKGROUND: Pelvic floor training with biofeedback has been shown to 
      significantly reduce symptoms of urinary incontinence. The present study aimed to 
      evaluate the effectiveness of pelvic floor training with the ACTICORE1 
      biofeedback device, which uses a noninsertable pelvic floor sensor with a digital 
      interface. MATERIALS AND METHODS: A multicenter randomized controlled clinical 
      pilot study in Germany was conducted between October 2021 and January 2022. The 
      intervention group was instructed to use ACTICORE1 for 6 min daily to train the 
      pelvic floor for 12 weeks. The control group was instructed not to do any pelvic 
      floor training. Over 18-year-old men and women with urinary incontinence and an 
      International Consultation on Incontinence Questionnaire score (ICIQ) of >/=5 were 
      included in the study. The primary endpoint was the ICIQ score 12 weeks after 
      enrollment. The secondary endpoints were the ICIQ score and quality of life using 
      the EG-5D-3L questionnaire 4, 8, and 12 weeks after patients' enrollment. 
      RESULTS: A total of 40 individuals with urinary incontinence were recruited for 
      the present study (35 females, 5 males; 40% lost to follow-up). In terms of 
      biometric data, both groups did not differ. At 4, 8, and 12 weeks, the ICIQ 
      scores of those in the ACTICORE1 group decreased from 12.9 to 7.5. The ICIQ score 
      in the control group decreased from 11.0 to 10.5. The intraindividual improvement 
      of patients in the ACTICORE group was statistically significant. CONCLUSION: 
      Biofeedback training with ACTICORE1 significantly reduces symptoms of urinary 
      incontinence after 12 weeks.
CI  - Copyright (c) 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
FAU - Paasch, Christoph
AU  - Paasch C
AUID- ORCID: 0000-0003-3104-8288
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
FAU - Soeder, Sonja
AU  - Soeder S
AD  - Physiotherapy Practice Soeder, Berlin.
AD  - Visceral Vascular Surgery, Minimally Invasive Surgery Alexianer St. Hedwig 
      Hospital.
FAU - Lorenz, Eric
AU  - Lorenz E
AD  - Visceral Vascular Surgery, Minimally Invasive Surgery Alexianer St. Hedwig 
      Hospital.
FAU - Heisler, Sophie
AU  - Heisler S
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
FAU - Gotze, Matthias
AU  - Gotze M
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
FAU - Borgmann, Hendrik
AU  - Borgmann H
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
FAU - Olthoff, Julia
AU  - Olthoff J
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
FAU - Hunerbein, Michael
AU  - Hunerbein M
AD  - Department of Surgery, Oberhavel Klinik Oranienburg, Oranienburg, Germany.
FAU - Hunger, Richard
AU  - Hunger R
AD  - Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor 
      Fontane, Brandenburg.
FAU - Mantke, Rene
AU  - Mantke R
AD  - University Hospital Brandenburg an der Havel, Brandenburg Medical University.
AD  - Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor 
      Fontane, Brandenburg.
LA  - eng
PT  - Journal Article
DEP - 20230818
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC10553154
OTO - NOTNLM
OT  - ACTICORE1
OT  - biofeedback training
OT  - stress incontinence
OT  - urge incontinence
OT  - urinary incontinency
COIS- C.P., R.H., and S.S. received payment for conducting the study from ACTICORE 
      AG.Sponsorships or competing interests that may be relevant to content are 
      disclosed at the end of this article.
EDAT- 2023/10/09 12:42
MHDA- 2023/10/09 12:43
PMCR- 2023/08/18
CRDT- 2023/10/09 06:12
PHST- 2023/06/29 00:00 [received]
PHST- 2023/08/04 00:00 [accepted]
PHST- 2023/10/09 12:43 [medline]
PHST- 2023/10/09 12:42 [pubmed]
PHST- 2023/10/09 06:12 [entrez]
PHST- 2023/08/18 00:00 [pmc-release]
AID - AMSU-D-23-01416 [pii]
AID - 10.1097/MS9.0000000000001181 [doi]
PST - epublish
SO  - Ann Med Surg (Lond). 2023 Aug 18;85(10):4860-4865. doi: 
      10.1097/MS9.0000000000001181. eCollection 2023 Oct.